Interventional Cardiology Devices Market to Hit US$ 37.27 Billion by 2029 with 6.0% CAGR | MarketsandMarkets Trademark

The interventional cardiology devices market in North America is growing highly because of increased prevalence of cardiovascular diseases, an aged population, and minimal development in procedures. Heart disease is the great killer, and so this leads to a higher requirement for innovative and efficient intervention solutions.
The global interventional cardiology devices market [https://www.marketsandmarkets.com/Market-Reports/minimally-invasive-interventional-cardiology-devices-market-548.html?utm_source=abnewswire.com&utm_medium=paidpr&utm_campaign=interventionalcardiologydevicesmarket], valued at US$26.32 billion in 2023, is forecasted to grow at a robust CAGR of 6.0%, reaching US$27.80 billion in 2024 and an impressive US$37.27 billion by 2029. The growth of this market is prompted by several factors. Rising rates of cardiovascular diseases, fueled by aging populations, unhealthy lifestyles, and increased prevalence of obesity and diabetes, create a growing demand for minimally invasive treatment options. Technological advancements in interventional devices, such as drug-eluting stents, bioresorbable vascular scaffolds, and transcatheter valves, are enhancing treatment outcomes and patient safety, thus increasing adoption is expected to drive the growth of interventional cardiology devices market.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=548 [https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=548&utm_source=abnewswire.com&utm_medium=paidpr&utm_campaign=interventionalcardiologydevicesmarket]

OPPORTUNITY: High growth potential in emerging markets

The merging markets hold significant growth potential in the interventional cardiology market due to increased access to healthcare, rising awareness of cardiovascular diseases, and improvement in medical infrastructure. Several geographies, such as the Asia-Pacific, Latin America, and parts of the Middle East, are experiencing fast-paced urbanization and economic growth, which is often associated with lifestyle-related diseases, including cardiovascular conditions. Intervening cardiology carries very attractive prospects of being more in demand due to increased demands brought on by aging populations and heart diseases.

Based on Angioplasty stent type, the interventional cardiology devices market has been segmented into drug-eluting stents, bare-metal stents & bioabsorbable stents. Drug-eluting stents (DES) offer several advantages in cardiovascular procedures compared to bare metal stents (BMS). One of the primary benefits is their ability to reduce the risk of restenosis, or the re-narrowing of the artery, which is a common complication after angioplasty. DES are coated with medication that is gradually released to inhibit cell proliferation and reduce scar tissue formation, thus significantly lowering the rates of restenosis-often by 50% or more compared to BMS.

Based on Catheters, the interventional cardiology devices market is segmented into angiography catheters, guiding catheters & IVUS/OCT catheter. In 2023, the angiography catheters segment accounted for the largest market share. Angiography catheters play a crucial role in cardiovascular procedures, offering several significant advantages. Firstly, they enable precise visualization of blood vessels, allowing healthcare providers to diagnose and assess conditions such as coronary artery disease, blockages, and aneurysms effectively. The design of these catheters, which includes various shapes and sizes tailored for specific vascular regions, enhances the ability to navigate through the complex anatomy of the cardiovascular system.

Based on plaque modification devices, the interventional cardiology devices market is segmented into thrombectomy devices & atherectomy devices. In 2023, thrombectomy devices segment accounted for the largest market share. Thrombectomy devices offer significant advantages in cardiovascular procedures, particularly in the treatment of acute coronary syndromes and peripheral artery disease. One key benefit is their ability to rapidly restore blood flow by mechanically removing thrombus (clots) from occluded vessels, thereby reducing ischemia and potentially saving myocardial tissue during myocardial infarction. These devices also minimize the need for systemic thrombolytic therapy, which carries risks of bleeding and other complications. By localizing the removal of clots, thrombectomy devices can enhance procedural safety and efficacy. Furthermore, advancements in device technology have led to improved success rates and shorter procedure times, contributing to better overall patient outcomes.

Request Sample Pages : https://www.marketsandmarkets.com/requestsampleNew.asp?id=548 [https://www.marketsandmarkets.com/requestsampleNew.asp?id=548&utm_source=abnewswire.com&utm_medium=paidpr&utm_campaign=interventionalcardiologydevicesmarket]

Based on end user, the interventional cardiology devices market is segmented into hospitals, ambulatory surgical centers & other end users. The other end users include Cath labs, cardiac centers. In 2023, hospitals took the largest share in interventional cardiology devices market. Most interventional cardiology procedures are conducted in hospital settings, where specialized facilities and equipment are readily available to handle complex procedures safely. Hospitals are equipped with catheterization labs, or Cath labs, that provide the necessary environment for a range of interventions, such as angioplasty and stenting, coronary artery bypass grafting (CABG), and transcatheter aortic valve replacement (TAVR). These settings also ensure immediate access to critical care services and emergency interventions if needed.

In 2023, North America accounted for the largest share of the interventional cardiology devices market, followed by Europe and Asia Pacific. Interventional cardiology in North America is experiencing rapid advancements, driven by technological innovations and increasing demand for minimally invasive procedures. The region has seen notable progress in catheter-based technologies, imaging techniques, and stent designs, which together enhance the accuracy, safety, and success rates of interventions. Drug-eluting stents (DES), bioresorbable vascular scaffolds, and newer iterations of drug-coated balloons are widely used, with more advanced versions continually emerging to improve patient outcomes. Additionally, sophisticated imaging techniques, such as optical coherence tomography (OCT) and intravascular ultrasound (IVUS), allow cardiologists to visualize blood.

The prominent players operating in the interventional cardiology devices market are Boston Scientific Corporation (US), Medtronic (US), Abbott (US), B. Braun SE (Germany), Terumo Corporation (Japan), Edwards Lifesciences Corporation (US), Koninklijke Philips N.V. (Netherlands), Integer Holdings Corporation (US), Teleflex Incorporated (US), Penumbra, Inc. (US), Cook (US), Cordis (US), iVascular S.L.U (Spain), Biosensors International Group, Ltd (Singapore), BIOTRONIK SE & Co. KG (Germany), AMG International (Germany), ENDOCOR GmbH (Germany), InSitu Technologies, Inc. (US), Meril Life Sciences (India), Alvimedica (Istanbul), Cardionovum GmBH (Germany), Medinol Ltd (Turkey), Wellinq (Netherlands), Balton SP (Poland), Translumina (India).

For more information, Inquire Now! [https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=548&utm_source=abnewswire.com&utm_medium=paidpr&utm_campaign=interventionalcardiologydevicesmarket]

Media Contact
Company Name: MarketsandMarkets Trademark Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=interventional-cardiology-devices-market-to-hit-us-3727-billion-by-2029-with-60-cagr-marketsandmarkets]
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/minimally-invasive-interventional-cardiology-devices-market-548.html

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.